Medication Management Software (MMS) refers to integrated digital platforms that enable healthcare providers, pharmacies, and patients to prescribe, dispense, administer, and monitor medications throughout the care continuum. Its relevance has surged as health systems strive for safety, compliance, and cost‑efficiency in drug therapy.
The Medication Management Software market size reached approximately $2.3 billion in 2025, and analysts project a robust growth outlook with a compound annual growth rate (CAGR) of about 11% from 2026 to 2033. This market forecast reflects accelerating industry expansion driven by value‑based care models, regulatory mandates for electronic prescribing, and the rise of telehealth‑enabled adherence solutions. Key forces shaping the market include rapid adoption of AI‑powered decision support, stringent FDA and CMS regulations on medication safety, and heightened consumer demand for personalized medication management tools. North America remains the largest market, while the Asia‑Pacific region is emerging as the fastest‑growing segment due to expanding healthcare infrastructure and digital health initiatives.